BioNukleo

[BioNukleo @BioNukleo]

New in J Biotechnol: Biocatalyst immobilization with more than 300 h stability and almost 3 months storage without activity loss: https://t.co/SpxgFu4Gz8

[Katharina #offline @katharinapaulic]

This evening we will discuss with impressing femal founders about leading a company thanks@DexLeChem @Alphazirkel https://t.co/V3kMtQRqjr

[BioNukleo @BioNukleo]

Significant anti-tumor activity by E.coli PNPs and Gene Directed Prodrug Enzyme Therapy: https://t.co/LJnAUXBecJ

[BioNukleo @BioNukleo]

Great! Sonja Jost inspires young students for a startup career: ttps://www.morgenpost.de/212291559?__pwh=X9WkkAMKeYzBmjX48mQtfg==

[BioNukleo @BioNukleo]

Exciting talks about new perspectives in medicine using AI and big data approaches at #futuremed17 #sciencematch

[BioNukleo @BioNukleo]

One step forward in the fight against multidrug resistant bacteria: https://t.co/gkmSae9MlC

[BioNukleo @BioNukleo]

Long term study of patients with Hairy cell leukemia diagnosed between 1995 and 2013: https://t.co/MUwPkBtzT0

[BioNukleo @BioNukleo]

BioNukleo is a part of the Network for Pharma Solutions, Germany:
https://t.co/jQfNxVRkxy

[BioNukleo @BioNukleo]

European Commission Grants Approval for Mavenclad (Cladribine Tablets) https://t.co/2lxxw4Cjcy

[BioNukleo @BioNukleo]

German article: Nukleosideanalogon Cladribin senkt die Schubrate bei MS Patienten- EU Zulassung https://t.co/WgFQVgeCX7

[BioNukleo @BioNukleo]

The thiopurine nucleoside analogue 6-methylmercaptopurine riboside (6MMPr) effectively blocks zika virus replication
https://t.co/vRXKJe5o8G

[DexLeChem @DexLeChem]

Yeeeah: DexLeChem CEO @SonjaJost was voted as one of the #25women who change the world" #GreenChemistry #BigBusiness

[BioNukleo @BioNukleo]

The Impact Factor for Nucleic Acids Research has gone up! Check out content from the journal https://t.co/d7eb0Mg7EJ @NAR_Open

[BioNukleo @BioNukleo]

SOFINNOVA:The next big thing in biotech: immuno-oncology. We are providing new drugs to the market. #LBRefresh

[BangeBalcony @BangeBalcony]

Interested in enzyme design? https://t.co/AHqEmTHC6y

[Katharina #offline @katharinapaulic]

BioNukleo will present it's technology at german biotechnology days in Hannover, meet us at April 5 13:30 in Saal 1B
https://t.co/andpb9b19o

[UNESCO @UNESCO]

Today we celebrate #WomenInScience because gender equality and women’s empowerment are pre-conditions 4 sustainable development

[Katharina #offline @katharinapaulic]

https://t.co/bKe9sZPalj

[BioNukleo @BioNukleo]

Symposium: PROZESSSCHRITTE OPTIMIEREN – NEUE POTENTIALE FÜR DIE BIOTECHNOLOGIE
https://t.co/ZNKCOZGjih

[BioNukleo @BioNukleo]

Melanoma addiction to the long non-coding RNA SAMMSON. - PubMed - NCBI https://t.co/KbrYRWtZaT